877830017	877830017	CD	B-NP	O
|	|	NN	I-NP	O
VMH	VMH	NN	I-NP	O
|	|	NN	I-NP	O
98804941	98804941	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4609148	4609148	CD	B-NP	O
|	|	CC	I-NP	O
3/18/2005	3/18/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
ICD	ICD	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/18/2005	8/18/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/21/2005	3/21/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
COOPERWOOD	COOPERWOOD	NN	I-NP	O
,	,	,	O	O
GLEN	GLEN	NNP	B-NP	O
090-61-53-6	090-61-53-6	NNP	I-NP	O
Ny	Ny	NNP	I-NP	O
Villea	Villea	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/23/05	10/23/05	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ZANIS	ZANIS	NN	B-NP	B-protein
,	,	,	O	O
CLEO	CLEO	NNP	B-NP	O
BERNIE	BERNIE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/6/05	6/6/05	CD	B-NP	O
by	by	IN	B-PP	O
ZACHMANN	ZACHMANN	NNP	B-NP	O
,	,	,	O	O
JONATHON	JONATHON	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
both	both	CC	O	O
INSULIN	INSULIN	NNP	B-NP	B-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/6/05	6/6/05	CD	B-NP	O
by	by	IN	B-PP	O
KRUIS	KRUIS	NN	B-NP	B-protein
,	,	,	O	O
MAJOR	MAJOR	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TRICOR	TRICOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
67425424	67425424	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
INR	INR	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/6/05	6/6/05	CD	B-NP	O
by	by	IN	B-PP	O
BICE	BICE	NNP	B-NP	O
,	,	,	O	O
DALTON	DALTON	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
23465385	23465385	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
both	both	CC	O	O
KEFLEX	KEFLEX	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
CEPHALEXIN	CEPHALEXIN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	I-NP	O
250	250	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QID	QID	NN	I-NP	O
X	X	SYM	B-VP	O
12	12	CD	B-NP	O
doses	dose	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
when	when	WRB	B-ADVP	O
IV	IV	CD	B-NP	O
ANTIBIOTICS	ANTIBIOTICS	NNP	I-NP	O
END	END	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
TRICOR	TRICOR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
145	145	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/6/05	6/6/05	CD	B-NP	O
by	by	IN	B-PP	O
DEPPEN	DEPPEN	NNP	B-NP	O
,	,	,	O	O
VINCENT	VINCENT	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
INR	INR	NNP	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
lifting	lifting	NN	I-NP	O
and	and	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
lift	lift	VB	I-VP	O
L	L	NN	B-NP	B-protein
elbow	elbow	NN	I-NP	I-protein
above	above	IN	B-PP	I-protein
L	L	NN	B-NP	I-protein
shoulder	shoulder	NN	I-NP	I-protein
x	x	SYM	O	I-protein
1	1	CD	B-NP	I-protein
month	month	NN	I-NP	I-protein
FOLLOW	FOLLOW	NNP	I-NP	I-protein
UP	UP	NNP	I-NP	I-protein
APPOINTMENT	APPOINTMENT	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Vuckovich	Vuckovich	NNP	I-NP	O
November	November	NNP	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
11/18/05	11/18/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
4-7	4-7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
ICD	ICD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ICD	ICD	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CHF	CHF	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	B-protein
surgery	surgery	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
dm	dm	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
htn	htn	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hypertension	hypertension	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
hyperchol	hyperchol	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
elevated	elevated	JJ	I-NP	I-protein
cholesterol	cholesterol	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
cri	cri	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
dual	dual	JJ	I-NP	O
chamber	chamber	NN	I-NP	O
ICD	ICD	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
69	69	CD	B-NP	O
y/o	y/o	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
25-30	25-30	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
admit	admit	NN	I-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
ablation	ablation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NSVT	NSVT	NN	B-NP	B-protein
.	.	.	O	O

Primary	Primary	JJ	B-NP	O
prevention	prevention	NN	I-NP	O
ICD	ICD	NN	I-NP	O
placed	place	VBN	B-VP	O
without	without	IN	B-PP	O
complicaiton	complicaiton	NN	B-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
short	short	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
AF	AF	NN	B-NP	O
during	during	IN	B-PP	O
procedure	procedure	NN	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
baby	baby	NN	B-NP	O
ASA	ASA	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
h/o	h/o	NN	I-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Continue	Continue	JJ	B-NP	O
coumadin	coumadin	NN	I-NP	O
5mg	5mg	CD	I-NP	O
each	each	DT	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

Have	Have	VB	B-VP	O
your	your	PRP$	B-NP	O
INR/coumadin	INR/coumadin	NN	I-NP	O
level	level	NN	I-NP	O
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
May	May	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WEALER	WEALER	NNP	B-NP	O
,	,	,	O	O
ROYAL	ROYAL	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
PA-C	PA-C	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
HB35	HB35	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
10/23/05	10/23/05	CD	B-NP	O
@	@	SYM	I-NP	O
10	10	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

